ORIC
Price
$7.64
Change
-$0.36 (-4.50%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
568.21M
62 days until earnings call
PHVS
Price
$14.95
Change
-$0.06 (-0.40%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
808.07M
44 days until earnings call
Ad is loading...

ORIC vs PHVS

Header iconORIC vs PHVS Comparison
Open Charts ORIC vs PHVSBanner chart's image
Oric Pharmaceuticals
Price$7.64
Change-$0.36 (-4.50%)
Volume$19.15K
Capitalization568.21M
Pharvaris
Price$14.95
Change-$0.06 (-0.40%)
Volume$217
Capitalization808.07M
ORIC vs PHVS Comparison Chart
Loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORIC vs. PHVS commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a Hold and PHVS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ORIC: $8.00 vs. PHVS: $15.01)
Brand notoriety: ORIC and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORIC: 29% vs. PHVS: 185%
Market capitalization -- ORIC: $568.21M vs. PHVS: $808.07M
ORIC [@Biotechnology] is valued at $568.21M. PHVS’s [@Biotechnology] market capitalization is $808.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • ORIC’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ORIC and PHVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 6 TA indicator(s) are bullish while PHVS’s TA Score has 4 bullish TA indicator(s).

  • ORIC’s TA Score: 6 bullish, 5 bearish.
  • PHVS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ORIC is a better buy in the short-term than PHVS.

Price Growth

ORIC (@Biotechnology) experienced а -0.37% price change this week, while PHVS (@Biotechnology) price change was -5.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

ORIC is expected to report earnings on May 12, 2025.

PHVS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($808M) has a higher market cap than ORIC($568M). ORIC YTD gains are higher at: -0.867 vs. PHVS (-21.701). PHVS (-127.53M) and ORIC (-133.69M) have comparable annual earnings (EBITDA) . PHVS has more cash in the bank: 305M vs. ORIC (272M). PHVS has less debt than ORIC: PHVS (117K) vs ORIC (3.12M). ORIC (0) and PHVS (0) have equivalent revenues.
ORICPHVSORIC / PHVS
Capitalization568M808M70%
EBITDA-133.69M-127.53M105%
Gain YTD-0.867-21.7014%
P/E RatioN/AN/A-
Revenue00-
Total Cash272M305M89%
Total Debt3.12M117K2,668%
TECHNICAL ANALYSIS
Technical Analysis
ORICPHVS
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGJAX18.510.09
+0.49%
Nuveen Global Real Estate Securities A
VRTIX318.761.42
+0.45%
Vanguard Russell 2000 Index I
IASCX13.860.06
+0.43%
Voya Small Company Port A
AABCX15.270.04
+0.26%
Putnam Dynamic Asset Allocation Bal C
CEKRX13.770.02
+0.15%
Columbia Emerging Markets Inst2

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+1.91%
KYMR - ORIC
45%
Loosely correlated
+1.08%
ATXS - ORIC
42%
Loosely correlated
-3.58%
BPMC - ORIC
42%
Loosely correlated
-1.60%
IDYA - ORIC
40%
Loosely correlated
-3.20%
ARVN - ORIC
40%
Loosely correlated
+1.22%
More

PHVS and

Correlation & Price change

A.I.dvisor tells us that PHVS and MLTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHVS and MLTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-2.85%
MLTX - PHVS
30%
Poorly correlated
-4.48%
AVTE - PHVS
26%
Poorly correlated
+1.20%
ARVN - PHVS
25%
Poorly correlated
+1.22%
ORIC - PHVS
25%
Poorly correlated
+1.91%
MESO - PHVS
24%
Poorly correlated
-1.54%
More